The ADC binds Trop-2 on tumor cells, is internalized, and releases SN-38, which inhibits DNA topoisomerase I to cause DNA breaks and apoptosis; killing is determined by Trop-2 targeting (with a bystander effect), not by direct recognition of topoisomerase I.